Nicotine-induced enhancement of synaptic plasticity at CA3-CA1 synapses requires GABAergic interneurons in adult anti-NGF mice

Journal of Physiology

Volumn 576, Issue 2, 2006, Pages 361-377

  Rosato Siri, Marcelo ^a   Cattaneo, Antonino ^a,b   Cherubini, Enrico ^a  

^a SISSA   (Italy)

^b Lay Line Genomics SpA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; CORTICOTROPIN DERIVATIVE; NERVE GROWTH FACTOR ANTIBODY; NICOTINE; BUNGAROTOXIN RECEPTOR; NERVE GROWTH FACTOR; NICOTINIC RECEPTOR BETA2;

ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLINERGIC NERVE CELL; CHOLINERGIC TRANSMISSION; COGNITION; CONTROLLED STUDY; EXCITATORY POSTSYNAPTIC POTENTIAL; FEMALE; GABAERGIC SYSTEM; GABAERGIC TRANSMISSION; HIPPOCAMPUS; INTERNEURON; LONG TERM POTENTIATION; MALE; MOUSE; NERVE CELL PLASTICITY; NERVE DEGENERATION; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NEUROTRANSMITTER RELEASE; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; PROTEIN DEPLETION; SYNAPTIC POTENTIAL; TRANSGENIC MOUSE; WHOLE CELL; WILD TYPE; BRAIN ELECTROPHYSIOLOGY; CHOLINERGIC SYSTEM; HIPPOCAMPAL CA1 REGION; HIPPOCAMPAL CA3 REGION; HIPPOCAMPAL SLICE; PROTEIN SECRETION; REGULATORY MECHANISM; SYNAPTIC TRANSMISSION; WHOLE CELL PATCH CLAMP;

ALZHEIMER DISEASE; ANIMALS; DISEASE MODELS, ANIMAL; EXCITATORY POSTSYNAPTIC POTENTIALS; FEMALE; GAMMA-AMINOBUTYRIC ACID; GANGLIONIC STIMULANTS; HIPPOCAMPUS; INTERNEURONS; LONG-TERM POTENTIATION; MALE; MICE; MICE, TRANSGENIC; NERVE GROWTH FACTOR; NEURONAL PLASTICITY; NICOTINE; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, NICOTINIC; SYNAPSES; SYNAPTIC TRANSMISSION;

EID: 33749331275     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2006.114587     Document Type: Article

References (58)

1. Alkondon M & Albuquerque EX (2004). The nicotinic acetylcholine receptor subtypes and their function in the hippocampus and cerebral cortex. Prog Brain Res 145, 109-120.
2. Bartus RT, Dean RL 3rd, Beer B & Lippa AS (1982). The cholinergic hypothesis of geriatric memory dysfunction. Science 217, 408-414.
3. Bear MF (1999). Homosynaptic long-term depression: A mechanism for memory?Proc Natl Acad Sci U S A 96, 9457-9458.
4. Bear MF & Malenka RC (1994). Synaptic plasticity: LTP and LTD. Curr Opin Neurobiol 4, 389-399.
5. Ben-Ari Y (2002). Excitatory actions of GABA during development: The nature of the nurture. Nat Rev Neurosci 3, 728-739.
6. Bertrand D, Bertrand S & Ballivet M (1992). Pharmacological properties of the homomeric alpha 7 receptor. Neurosci Lett 146, 87-90.
7. Bliss TV & Collingridge GL (1993). A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361, 31-39.
8. Capsoni S, Giannotta S & Cattaneo A (2002a). Nerve growth factor and galantamine ameliorate early signs of neurodegeneration in anti-nerve growth factor mice. Proc Natl Acad Sci U S A 99, 12432-12437.
9. Capsoni S, Giannotta S & Cattaneo A (2002b). Beta-amyloid plaques in a model for sporadic Alzheimer's disease based on transgenic anti-nerve growth factor antibodies. Mol Cell Neurosci 21, 15-28.
10. Capsoni S, Ugolini G, Comparini A, Ruberti F, Berardi N & Cattaneo A (2000). Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice. Proc Natl Acad Sci U S A 97, 6826-6831.
11. Cattaneo A, Capsoni S, Margotti E, Righi M, Kontsekova E, Pavlik P, Filipcik P & Novak M (1999). Functional blockade of tyrosine kinase A in the rat basal forebrain by a novel antagonistic anti-receptor monoclonal antibody. J Neurosci 19, 9687-9697.
12. Cattaneo A, Rapposelli B & Calissano P (1988). Three distinct types of monoclonal antibodies after long-term immunization of rats with mouse nerve growth factor. J Neurochem 50, 1003-1010.
13. Cherubini E, Gaiarsa JL & Ben-Ari Y (1991). GABA: An excitatory transmitter in early postnatal life. Trends Neurosci 14, 515-519.
14. Cotman CW & Anderson AJ (1995). A potential role for apoptosis in neurodegeneration and Alzheimer's disease. Mol Neurobiol 10, 19-45.
15. De Rosa R, Garcia AA, Braschi C, Capsoni S, Maffei L, Berardi N & Cattaneo A (2005). Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD 11 anti-NGF transgenic mice. Proc Natl Acad Sci U S A 102, 3811-3816.
16. Debeir T, Saragovi HU & Cuello AC (1999). A nerve growth factor mimetic TrkA antagonist causes withdrawal of cortical cholinergic boutons in the adult rat. Proc Natl Acad Sci U S A 96, 4067-4072.
17. Decker MW, Majchrzak MJ & Anderson DJ (1992). Effects of nicotine on spatial memory deficits in rats with septal lesions. Brain Res 572, 281-285.
18. Demuro A, Palma E, Eusebi F & Miledi R (2001). Inhibition of nicotinic acetylcholine receptors by bicuculline. Neuropharmacology 41, 854-861.
19. Fabian-Fine R, Skehel P, Errington ML, Davies HA, Sher E, Stewart MG & Fine A (2001). Ultrastructural distribution of the alpha7 nicotinic acetylcholine receptor subunit in rat hippocampus. J Neurosci 21, 7993-8003.
20. Freund TF & Buzsaki G (1996). Interneurons of the hippocampus. Hippocampus 6, 347-470.
21. Fujii S, Ji Z, Morita N & Sumikawa K (1999). Acute and chronic nicotine exposure differentially facilitate the induction of LTP. Brain Res 846, 137-143.
22. Ge S & Dani JA (2005). Nicotinic acetylcholine receptors at glutamate synapses facilitate long-term depression or potentiation. J Neurosci 25, 6084-6091.
23. Gray R, Rajan AS, Radcliffe KA, Yakehiro M & Dani JA (1996). Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature 383, 713-716.
24. Hefti F (1986). Nerve growth factor promotes survival of septal cholinergic neurons after fimbrial transections. J Neurosci 6, 2155-2162.
25. Jang IS, Ito Y & Akaike N (2005). Feed-forward facilitation of glutamate release by presynaptic GABA(A) receptors. Neuroscience 135, 737-748.
26. Ji D & Dani JA (2000). Inhibition and disinhibition of pyramidal neurons by activation of nicotinic receptors on hippocampal interneurons. J Neurophysiol 83, 2682-2690.
27. Ji D, Lape R & Dani JA (2001). Timing and location of nicotinic activity enhances or depresses hippocampal synaptic plasticity. Neuron 31, 131-141.
28. Jones GM, Sahakian BJ, Levy R, Warburton DM & Gray JA (1992). Effects of acute subcutaneous nicotine on attention, information processing and short-term memory in Alzheimer's disease. Psychopharmacology (Berl) 108, 485-494.
29. Jouvenceau A, Billard JM, Lamour Y & Dutar P (1996). Persistence of CA1 hippocampal LTP after selective cholinergic denervation. Neuroreport 7, 948-952.
30. Kawai H, Zago W & Berg DK (2002). Nicotinic alpha 7 receptor clusters on hippocampal GABAergic neurons: Regulation by synaptic activity and neurotrophins. J Neurosci 22, 7903-7912.
31. 2 regulation of nicotinic acetylcholine receptor channels in rat hippocampal CA1 neurons. J Neurosci 23, 9024-9031.
32. Levin ED, Christopher NC, Briggs SJ & Rose JE (1993). Chronic nicotine reverses working memory deficits caused by lesions of the fimbria or medial basalocortical projection. Brain Res Cogn Brain Res 1, 137-143.
33. Li Y, Holtzman DM, Kromer LF, Kaplan DR, Chua-Couzens J, Clary DO, Knusel B & Mobley WC (1995). Regulation of TrkA and ChAT expression in developing rat basal forebrain: Evidence that both exogenous and endogenous NGF regulate differentiation of cholinergic neurons. J Neurosci 15, 2888-2905.
34. McGehee DS (2002). Nicotinic receptors and hippocampal synaptic plasticity... it's all in the timing. Trends Neurosci 25, 171-172.
35. McGurk SR, Levin ED & Butcher LL (1991). Impairment of radial-arm maze performance in rats following lesions involving the cholinergic medial pathway: Reversal by arecoline and differential effects of muscarinic and nicotinic antagonists. Neuroscience 44, 137-147.
36. Maggi L, Le Magueresse C, Changeux JP & Cherubini E (2003). Nicotine activates immature 'silent' connections in the developing hippocampus. Proc Natl Acad Sci U S A 100, 2059-2064.
37. Maggi L, Sola E, Minneci F, Le Magueresse C, Changeux JP & Cherubini E (2004). Persistent decrease in synaptic efficacy induced by nicotine at Schaffer collateral-CA1 synapses in the immature rat hippocampus. J Physiol 559, 863-874.
38. Mann EO & Greenfield SA (2003). Novel modulatory mechanisms revealed by the sustained application of nicotine in the guinea-pig hippocampus in vitro. J Physiol 551, 539-550.
39. Mansvelder HD, Keath JR & McGehee DS (2002). Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas. Neuron 33, 905-919.
40. Miles R & Wong RK (1987). Inhibitory control of local excitatory circuits in the guinea-pig hippocampus. J Physiol 388, 611-629.
41. Molnar M, Tongiorgi E, Avignone E, Gonfloni S, Ruberti F, Domenici L & Cattaneo A (1998). The effects of anti-nerve growth factor monoclonal antibodies on developing basal forebrain neurons are transient and reversible. Eur J Neurosci 10, 3127-3140.
42. Nicoll RA & Malenka RC (1995). Contrasting properties of two forms of long-term potentiation in the hippocampus. Nature 377, 115-118.
43. Paterson D & Nordberg A (2000). Neuronal nicotinic receptors in the human brain. Prog Neurobiol 61, 75-111.
44. Payne JA, Rivera C, Voipio J & Kaila K (2003). Cation-chloride co-transporters in neuronal communication, development and trauma. Trends Neurosci 26, 199-206.
45. Perry E, Martin-Ruiz C, Lee M, Griffiths M, Johnson M, Piggott M, et al. (2000). Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewy body diseases. Eur J Pharmacol 393, 215-222.
46. Pesavento E, Capsoni S, Domenici L & Cattaneo A (2002). Acute cholinergic rescue of synaptic plasticity in the neurodegenerating cortex of anti-nerve-growth-factor mice. Eur J Neurosci 15, 1030-1036.
47. - co-transporter KCC2 renders GABA hyperpolarizing during neuronal maturation. Nature 397, 251-255.
48. Ruberti F, Capsoni S, Comparini A, Di Daniel E, Franzot J, Gonfloni S, Rossi G, Berardi N & Cattaneo A (2000). Phenotypic knockout of nerve growth factor in adult transgenic mice reveals severe deficits in basal forebrain cholinergic neurons, cell death in the spleen, and skeletal muscle dystrophy. J Neurosci 20, 2589-2601.
49. Ruiz A, Fabian-Fine R, Scott R, Walker MC, Rusakov DA & Kullmann DM (2003). GABAA receptors at hippocampal mossy fibers. Neuron 39, 961-973.
50. Sahakian BJ, Coull JJ & Hodges JR (1994). Selective enhancement of executive function by idazoxan in a patient with dementia of the frontal lobe type. J Neurol Neurosurg Psychiatr 57, 120-121.
51. Schulz PE & Fitzgibbons JC (1997). Differing mechanisms of expression for short- and long-term potentiation. J Neurophysiol 78, 321-334.
52. Selkoe DJ (2002). Alzheimer's disease is a synaptic failure. Science 298, 789-791.
53. Toth K, Freund TF & Miles R (1997). Disinhibition of rat hippocampal pyramidal cells by GABAergic afferents from the septum. J Physiol 500, 463-474.
54. Tuszynski MH, Thal L, Pay M, Salmon DPU HS, Bakay R et al. (2005). A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat Med 11, 551-555.
55. Yamazaki Y, Hamaue N & Sumikawa K (2002). Nicotine compensates for the loss of cholinergic function to enhance long-term potentiation induction. Brain Res 946, 148-152.
56. Yamazaki Y, Jia Y, Hamaue N & Sumikawa K (2005). Nicotine-induced switch in the nicotinic cholinergic mechanisms of facilitation of long-term potentiation induction. Eur J Neurosci 22, 845-860.
57. Zoli M, Lena C, Picciotto MR & Changeux JP (1998). Identification of four classes of brain nicotinic receptors using beta2 mutant mice. J Neurosci 18, 4461-4472.
58. Zucker RS (1989). Short-term synaptic plasticity. Annu Rev Neurosci 12, 13-31.